109 related articles for article (PubMed ID: 8093087)
1. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
Kassab JP; Guillot R; Andre J; Claperon N; Bellon G; Feldmann G; Peyroux J; Sternberg M
Biochem Pharmacol; 1994 Aug; 48(5):1003-8. PubMed ID: 8093087
[TBL] [Abstract][Full Text] [Related]
2. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
3. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase and the development of renal disease in diabetic dogs.
Kern TS; Engerman RL
J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
[TBL] [Abstract][Full Text] [Related]
5. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
6. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
Cohen MP; Klepser H; Wu VY
Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
[TBL] [Abstract][Full Text] [Related]
8. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
Das A; Frank RN; Zhang NL
Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806
[TBL] [Abstract][Full Text] [Related]
9. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
10. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
Cohen MP
Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
[TBL] [Abstract][Full Text] [Related]
12. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
Cohen MP; Klepser H; Cua E
Biochim Biophys Acta; 1986 Apr; 876(2):226-32. PubMed ID: 3006784
[TBL] [Abstract][Full Text] [Related]
13. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
McCormack AJ; Hak LJ; Finn WF
Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
[TBL] [Abstract][Full Text] [Related]
14. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.
Sellers DJ; Chess-Williams R
J Auton Pharmacol; 2000 Feb; 20(1):15-22. PubMed ID: 11048957
[TBL] [Abstract][Full Text] [Related]
15. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
Sellers DJ; Chess-Williams R
J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
[TBL] [Abstract][Full Text] [Related]
16. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
Das A; Frank RN; Zhang NL; Samadani E
Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
[TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
18. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
20. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]